But don't listen to me, I have absolutely no medical training. And since I'm stroke-addled my reasoning skills are non-existent. I will get some after my next stroke even if I have to travel to one of these states or Uruguay or Netherlands or North Korea and soon Canada.
- Records of consecutive patients admitted with aSAH between 2010 and 2015 were reviewed.
- Clinical features and outcomes of aSAH patients with negative urine drug screen and cannabinoids-positive (CB+) were compared.
- Regression analyses were used to assess for associations.
- The study group consisted of 108 patients; 25.9% with CB+.
- Delayed cerebral ischemia was diagnosed in 50% of CB+ and 23.8% of urine drug screen negative patients (P=0.01).
- CB+ was independently associated with development of delayed cerebral ischemia (odds ratio, 2.68; 95% confidence interval, 1.03-6.99; P=0.01).
- A significantly higher number of CB+ than urine drug screen negative patients had poor outcome (35.7% versus 13.8%; P=0.01).
- In univariate analysis, CB+ was associated with the composite end point of hospital mortality/severe disability (odds ratio, 2.93; 95% confidence interval, 1.07-8.01; P=0.04).
- However, after adjusting for other predictors, this effect was no longer significant.